Celgene, Bristol-Myers Squibb, Teva Pharmaceuticals USA and other drugmakers were hit with an antitrust lawsuit on Oct. 6 in California Northern District Court. The lawsuit was brought by BRS LLP on behalf of Mayo Clinic and Lifepoint Corporate Services, which allege that the defendants have conspired to delay generic competition in the market for Revlimid, compelling the plaintiffs to pay maximum prices for the chemotherapy drug. Counsel have not yet appeared for the defendants. The case is 3:23-cv-05144, Mayo Clinic v. Celgene Corporation.
This suit was surfaced by Law.com Radar, a cutting edge solution for new suit alerts from federal and state courts. Law.com Radar delivers AI-enhanced case summaries and daily case reports from more than 1,100 courts—all backed by the industry's most trusted source for legal news and data. Click here to get started and be first to act on opportunities in your region, practice area or client sector.
Read the complaint here:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250